PlexBio Co., Ltd. (TPEX:6572)
Taiwan
· Delayed Price · Currency is TWD 11.10
+1.36 (13.96%)
Apr 29, 2026, 1:58 PM CST
PlexBio Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 127.1 | 128.06 | 167.18 | 191.19 | 124.94 | Upgrade
|
| Revenue Growth (YoY) | -0.76% | -23.40% | -12.56% | 53.02% | 23.28% | Upgrade
|
| Cost of Revenue | 86.68 | 78.8 | 104.71 | 132.19 | 86.38 | Upgrade
|
| Gross Profit | 40.41 | 49.26 | 62.47 | 59 | 38.56 | Upgrade
|
| Selling, General & Admin | 53.56 | 59.5 | 63.65 | 53.32 | 60.51 | Upgrade
|
| Research & Development | 52.5 | 69.29 | 62.97 | 72.61 | 113.31 | Upgrade
|
| Operating Expenses | 106.06 | 128.79 | 126.62 | 125.93 | 173.82 | Upgrade
|
| Operating Income | -65.65 | -79.53 | -64.15 | -66.94 | -135.26 | Upgrade
|
| Interest Expense | -0.27 | -0.16 | -0.26 | -0.17 | -0.23 | Upgrade
|
| Interest & Investment Income | 7.99 | 9.58 | 8.27 | 3.01 | 2.31 | Upgrade
|
| Currency Exchange Gain (Loss) | -4.63 | 7.84 | -2.88 | 10.06 | -2.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.09 | 0.63 | 0.49 | 0.9 | 4.08 | Upgrade
|
| EBT Excluding Unusual Items | -62.47 | -61.63 | -58.53 | -53.14 | -131.11 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -0.48 | Upgrade
|
| Pretax Income | -62.47 | -61.63 | -58.53 | -53.14 | -131.59 | Upgrade
|
| Net Income | -62.47 | -61.63 | -58.53 | -53.14 | -131.59 | Upgrade
|
| Net Income to Common | -62.47 | -61.63 | -58.53 | -53.14 | -131.59 | Upgrade
|
| Shares Outstanding (Basic) | 104 | 104 | 104 | 104 | 104 | Upgrade
|
| Shares Outstanding (Diluted) | 104 | 104 | 104 | 104 | 104 | Upgrade
|
| Shares Change (YoY) | - | - | - | 0.11% | 0.51% | Upgrade
|
| EPS (Basic) | -0.60 | -0.59 | -0.56 | -0.51 | -1.27 | Upgrade
|
| EPS (Diluted) | -0.60 | -0.59 | -0.56 | -0.51 | -1.27 | Upgrade
|
| Free Cash Flow | -79.52 | -8.64 | -32.11 | -73.02 | -95.94 | Upgrade
|
| Free Cash Flow Per Share | -0.77 | -0.08 | -0.31 | -0.70 | -0.93 | Upgrade
|
| Gross Margin | 31.80% | 38.46% | 37.37% | 30.86% | 30.86% | Upgrade
|
| Operating Margin | -51.65% | -62.10% | -38.38% | -35.01% | -108.26% | Upgrade
|
| Profit Margin | -49.15% | -48.13% | -35.01% | -27.79% | -105.32% | Upgrade
|
| Free Cash Flow Margin | -62.57% | -6.75% | -19.21% | -38.19% | -76.78% | Upgrade
|
| EBITDA | -58.06 | -69.67 | -55.06 | -55.76 | -121.46 | Upgrade
|
| EBITDA Margin | -45.68% | -54.40% | -32.93% | -29.17% | -97.21% | Upgrade
|
| D&A For EBITDA | 7.58 | 9.86 | 9.09 | 11.17 | 13.8 | Upgrade
|
| EBIT | -65.65 | -79.53 | -64.15 | -66.94 | -135.26 | Upgrade
|
| EBIT Margin | -51.65% | -62.10% | -38.37% | -35.01% | -108.26% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.